Sinovac Biotech Ltd. (SVA)
Market Open
11 Feb, 05:18
NASDAQ (NGS) NASDAQ (NGS) Primary $
6. 47
0
0%
$
464.94M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 6.47
Previous Close Want to track SVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.08 |
| | | - | 0.06 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.04 |
| | | - | - |
| | | - | 0 |
| | | - | 0 |
| | | - | - |
| | | - | 0 |
| | | - | 0.1 |
| | | - | 0.04 |
| | | - | 0.02 |
| | | - | - |
SVA Earnings Reports FAQ
What is the earnings per share (EPS) for SVA?
EPS data for SVA is currently not available, as Sinovac Biotech Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 57.47%, reflecting the SVA's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Sinovac Biotech Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sinovac Biotech Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SVA at this time, as Sinovac Biotech Ltd has no recent EPS data to calculate it.
